Magnan phenomenon is associated with which of the following drug use?
The core concept here is the pharmacological effect leading to the Magnan phenomenon. I think it's associated with antipsychotic drugs, particularly first-generation ones. The phenomenon involves extrapyramidal symptoms like dystonia, which can present as oculogyric crisis. That's when the eyes are fixed upward, and the patient might have muscle spasms in the neck or face.
So, the correct answer is likely a first-generation antipsychotic like haloperidol or chlorpromazine. Let's say the options included these. Why are these the right answer? Because they block dopamine D2 receptors in the nigrostriatal pathway, leading to EPS. The oculogyric crisis is a classic sign of acute dystonia from dopamine receptor blockade.
For the wrong options, if the other choices were second-generation antipsychotics like risperidone or olanzapine, those have a lower risk of EPS. Or maybe drugs from other classes like SSRIs or benzodiazepines, which don't typically cause this. Each of those would be incorrect because they don't block dopamine receptors in the same way.
The clinical pearl would be to remember that first-gen antipsychotics are more likely to cause acute dystonia, including the Magnan phenomenon. So, the key point is the dopamine receptor blockade leading to EPS, especially with older antipsychotics.
Now, structuring the explanation with the required sections. Core concept: Magnan phenomenon is acute dystonia from dopamine antagonist drugs. Correct answer is a first-gen antipsychotic. Wrong options are either second-gen or unrelated drugs. Clinical pearl: First-gen antipsychotics are high-yield for EPS.
**Core Concept**
Magnan phenomenon refers to acute dystonic reactions caused by dopamine receptor blockade, particularly in the nigrostriatal pathway. It is a classic extrapyramidal side effect of **antipsychotic medications**, characterized by oculogyric crisis (upward deviation of eyes), neck torsion, and facial grimacing.
**Why the Correct Answer is Right**
The Magnan phenomenon is most commonly associated with **typical (first-generation) antipsychotics** like *haloperidol* or *chlorpromazine*. These drugs block dopamine D2 receptors in the basal ganglia, disrupting motor control pathways. Acute dystonia arises within hours to days of initiation or dose escalation, with oculogyric crisis being a hallmark. Immediate treatment includes anticholinergics (e.g., benztropine) or diphenhydramine.
**Why Each Wrong Option is Incorrect**
**Option A:** *Second-generation antipsychotics* (e.g., risperidone, olanzapine) have lower D2 receptor occupancy and are less likely to cause acute dystonia.
**Option B:** *SSRIs* (e.g., fluoxetine) are linked to serotonin syndrome, not dystonia.
**Option C:** *Benzodiazepines* (e.g., dia